The new standard for assessing wellness.
We're bringing healthcare into the digital era using voice AI, replacing subjective measurements with objective, actionable data.
We believe in scaleable, data-driven insight into health - building smarter, more accessible, and more accurate care. Our goal is to improve both quality of care, and quality of life.
Canary's patented technology screens for mood, stress, and energy levels using a single 20-second audio clip. We're bringing seamless, non-invasive healthcare screening to every patient who needs it, everywhere.
Co-founders Henry O’Connell and Jeff Adams are two of speech and language technology’s most recognizable figures.
Their combined expertise in neurology research and speech technology – Henry at the National Institutes of Health, and Jeff leading Amazon Alexa’s founding speech AI team – drove them to explore the applications of speech technology in medicine. Speech and wellness are interwoven; vocal features reveal both emotional and physiological states. Henry and Jeff’s research into modeling these features and applying voice technology to healthcare built the framework for Canary Speech.
Nearly a decade later, Canary Speech holds three US patents and two European patents, and has been awarded more patents than any existing speech AI company.
In the early 1900s, long before digital readers existed, canaries were used in coal mines to detect life-threatening levels of toxic gases. Miners would bring caged canaries into the tunnels with them. If carbon monoxide or other dangerous gases were present – colorless, odorless, and undetectable—they would sicken the birds before the miners were affected. Canaries served as a signal for the miners to immediately exit the tunnels to safety.
At Canary Speech, vocal biomarkers are our signal—giving voice to previously silent health conditions earlier and more precisely. We believe in the power of preventive care and actionable, data-driven insight into invisible illnesses like anxiety, depression, and dementia.